FDA Approved: IDAMYCIN PFS — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for Idamycin PFS (idarubicin hydrochloride) from Pfizer, updating the drug’s approval to include a new dosage form.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• IDAMYCIN PFS (IDARUBICIN HYDROCHLORIDE)

Snippet

SUPPL AP for IDAMYCIN PFS (IDARUBICIN HYDROCHLORIDE)